Inogen (INGN) Gains from Sales and Divestitures (2018 - 2026)
Inogen (INGN) reported Gains from Sales and Divestitures of $70607.0 for Q1 2026, down 70.75% year-over-year from $241355.0 in Q1 2025, and down 39.37% quarter-over-quarter from $116450.0 in Q4 2025.
Inogen (INGN) Gains from Sales and Divestitures (2018 - 2026) Analysis & Trends
Inogen (INGN) has 9 years of Gains from Sales and Divestitures data on file, last reported at $70607.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $70607.0, down 70.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $70607.0 (down 70.75% YoY), and the FY2025 annual result was $116450.0, down 76.74% from the prior year.
- Gains from Sales and Divestitures eased to $70607.0 in Q1 2026 per INGN's latest filing, from $116450.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $500599.0 in Q4 2024 and troughed at $786.0 in Q3 2023.
- A 5-year average of $165796.4 and a median of $116450.0 in 2025 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2022 and 2024: Gains from Sales and Divestitures plunged 94.86% in 2022, then surged 49422.14% in 2024.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $5629.0 in 2022, then jumped by 177.46% to $15618.0 in 2023, then soared by 3105.27% to $500599.0 in 2024, then tumbled by 76.74% to $116450.0 in 2025, then slumped by 39.37% to $70607.0 in 2026.
- Business Quant data shows INGN's Gains from Sales and Divestitures at $70607.0 in Q1 2026, $116450.0 in Q4 2025, and $439625.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Inogen | 174.59 Mn | 80.18 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70,607.00 |
| Mar 31, 2026 | 70,607.00 |
| Dec 31, 2025 | 116,450.00 |
| Dec 31, 2025 | 116,450.00 |
| Sep 30, 2025 | 439,625.00 |
| Sep 30, 2025 | 439,625.00 |
| Jun 30, 2025 | 118,100.00 |
| Jun 30, 2025 | 118,100.00 |
| Mar 31, 2025 | 241,355.00 |
| Mar 31, 2025 | 241,355.00 |
| Dec 31, 2024 | 500,599.00 |
| Dec 31, 2024 | 500,599.00 |
| Sep 30, 2024 | 389,244.00 |
| Sep 30, 2024 | 389,244.00 |
| Jun 30, 2024 | 364,088.00 |
| Jun 30, 2024 | 364,088.00 |
| Mar 31, 2024 | 163,446.00 |
| Mar 31, 2024 | 163,446.00 |
| Dec 31, 2023 | 15,618.00 |
| Dec 31, 2023 | 15,618.00 |